290 related articles for article (PubMed ID: 22816881)
1. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
Janagond AB; Kanwar AJ; Handa S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
Carlin CS; Callis KP; Krueger GG
Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
[TBL] [Abstract][Full Text] [Related]
6. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of total glucosides of paeony combined with acitretin in the treatment of moderate-to-severe plaque psoriasis: a double-blind, randomised, placebo-controlled trial.
Yu C; Fan X; Li Z; Liu X; Wang G
Eur J Dermatol; 2017 Apr; 27(2):150-154. PubMed ID: 28400341
[TBL] [Abstract][Full Text] [Related]
8. Low-dose acitretin in treatment of plaque-type psoriasis: descriptive study of efficacy and safety.
Borghi A; Corazza M; Bertoldi AM; Caroppo F; Virgili A
Acta Derm Venereol; 2015 Mar; 95(3):332-6. PubMed ID: 24978351
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of acitretin in severe psoriasis.
Geiger JM
Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and Safety of Acitretin in Children with Plaque Psoriasis: A Multicenter Retrospective Analysis.
Di Lernia V; Bonamonte D; Lasagni C; Belloni Fortina A; Cambiaghi S; Corazza M; Di Nuzzo S; Gisondi P; Panzone M; Guarneri C; Neri I
Pediatr Dermatol; 2016 Sep; 33(5):530-5. PubMed ID: 27443789
[TBL] [Abstract][Full Text] [Related]
12. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of oxymatrine for treatment and relapse suppression of severe plaque psoriasis: results from a single-blinded randomized controlled clinical trial.
Zhou H; Shi HJ; Yang J; Chen WG; Xia L; Song HB; Bo KP; Ma W
Br J Dermatol; 2017 Jun; 176(6):1446-1455. PubMed ID: 28112799
[TBL] [Abstract][Full Text] [Related]
14. Brodalumab and ixekizumab, anti-interleukin-17-receptor antibodies for psoriasis: a critical appraisal.
Spuls PI; Hooft L
Br J Dermatol; 2012 Oct; 167(4):710-3; discussion 714-5. PubMed ID: 23013312
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of interleukin-2 and tumour necrosis factor-α under cyclosporine versus acitretin treatment in plaque-type psoriasis.
Akçali C; Guven EH; Kirtak N; Inaloz HS; Ozgoztasi O; Guvenc U
J Int Med Res; 2014 Oct; 42(5):1118-22. PubMed ID: 25143337
[TBL] [Abstract][Full Text] [Related]
16. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.
Bilia AR; Bergonzi MC; Isacchi B; Antiga E; Caproni M
J Pharm Pharmacol; 2018 Jul; 70(7):919-928. PubMed ID: 29600580
[TBL] [Abstract][Full Text] [Related]
17. Oral pimecrolimus in the treatment of moderate to severe chronic plaque-type psoriasis: a double-blind, multicentre, randomized, dose-finding trial.
Gottlieb AB; Griffiths CE; Ho VC; Lahfa M; Mrowietz U; Murrell DF; Ortonne JP; Todd G; Cherill R; Marks I; Emady-Azar S; Paul CF;
Br J Dermatol; 2005 Jun; 152(6):1219-27. PubMed ID: 15948985
[TBL] [Abstract][Full Text] [Related]
18. Acitretin.
Ortiz NE; Nijhawan RI; Weinberg JM
Dermatol Ther; 2013; 26(5):390-9. PubMed ID: 24099069
[TBL] [Abstract][Full Text] [Related]
19. A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis.
Ozdemir M; Engin B; Baysal I; Mevlitoğlu I
Acta Derm Venereol; 2008; 88(6):589-93. PubMed ID: 19002344
[TBL] [Abstract][Full Text] [Related]
20. Atorvastatin for the treatment of plaque-type psoriasis.
Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
